Cargando…

An Immunocompetent Patient with High Neutralizing Antibody Titers Who Shed COVID-19 Virus for 169 days — China, 2020

Detalles Bibliográficos
Autores principales:	Li, Li, Li, Siqi, Pan, Yang, Qin, Ling, Yang, Siyuan, Tan, Dawei, Hu, Yaling, Knoll, Maria Deloria, Wang, Xiaoli, Wang, Linghang, Wang, Quanyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021
Materias:	Notes from Field
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393007/ https://www.ncbi.nlm.nih.gov/pubmed/34594968 http://dx.doi.org/10.46234/ccdcw2021.163

Ejemplares similares

Factors Associated with SARS-CoV-2 Repeat Positivity — Beijing, China, June–September 2020
por: Li, Siqi, et al.
Publicado: (2022)

Correlation of Feline Coronavirus Shedding in Feces with Coronavirus Antibody Titer
por: Felten, Sandra, et al.
Publicado: (2020)

Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine
por: Giri, Sidhartha, et al.
Publicado: (2018)

Prolonged viral shedding in an immunocompetent patient with COVID-19
por: McKie, Anthony Michael, et al.
Publicado: (2020)

The First Outbreak of Omicron Subvariant BA.5.2 — Beijing Municipality, China, July 4, 2022
por: Feng, Zhaomin, et al.
Publicado: (2022)

High neutralizing antibody titer in intensive care unit patients with COVID-19
por: Liu, Li, et al.
Publicado: (2020)

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines
por: Kung, Yu-An, et al.
Publicado: (2023)

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

1180. Comparing Changes in Pneumococcal Meningitis Incidence to all Invasive Pneumococcal Disease Following Introduction of PCV10 and PCV13: The PSERENADE Project
por: Yang, Yangyupei, et al.
Publicado: (2021)

Study of the disintegration of erbium 169
por: Charpak, Georges, et al.
Publicado: (1959)

169th AAS Meeting
Publicado: (1987)

169th RB Meeting
Publicado: (2004)

Subject index for volume 169
Publicado: (1989)

Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
por: Urlaub, Doris, et al.
Publicado: (2022)

First Human Infection Case of Monkey B Virus Identified in China, 2021
por: Wang, Wenling, et al.
Publicado: (2021)

Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
por: Bar, Katharine J., et al.
Publicado: (2012)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
por: Rumfelt, Kalee E, et al.
Publicado: (2023)

Economic Burden of Hand, Foot, and Mouth Disease — Beijing Municipality, China, 2016–2019
por: Shen, Ying, et al.
Publicado: (2023)

A Local Cluster of Omicron Variant COVID-19 Likely Caused by Internationally Mailed Document — Beijing Municipality, China, January 2022
por: Zhang, Daitao, et al.
Publicado: (2022)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system
por: Luo, Xiaoyi, et al.
Publicado: (2023)

Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
por: Bi, Yanzhen, et al.
Publicado: (2020)

RNF169 flips the repair switch
por: Leslie, Mitch
Publicado: (2012)

Chromoblastomycosis in India: Review of 169 cases
por: Agarwal, Reshu, et al.
Publicado: (2017)

Health Tract, No. 169: Medical Items
Publicado: (1863)

Health Tract, No. 169: Medical Items
Publicado: (1865)

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
por: Miyaji, Karina Takesaki, et al.
Publicado: (2017)

Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies
por: Manukyan, Hasmik, et al.
Publicado: (2020)

Osa-miR169 Negatively Regulates Rice Immunity against the Blast Fungus Magnaporthe oryzae
por: Li, Yan, et al.
Publicado: (2017)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
por: Sitaras, Ioannis, et al.
Publicado: (2022)

Bilateral asymmetrical herpes-zoster with Ramsay hunt syndrome in an immunocompetent adult
por: Dai, Siqi, et al.
Publicado: (2020)

Identification and Characterization of MiRNAs in Coccomyxa subellipsoidea C-169
por: Yang, Runqing, et al.
Publicado: (2019)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
por: Connelly, Guinevere G., et al.
Publicado: (2022)

Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against Influenza A virus
por: Li, Hua, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_1o4ldlsk4l1slq1nsvmbd7bl5i